Authors

Geoffrey Young, Miami Cancer InstituteFollow

A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis

Publication Date

12-1-2024

Content Type

Article

PubMed ID:

39096091

Additional Authors:

Additional authors and institutional affiliations

Citation

Best, S. R., Bock, J. M., Fowler, N. B., Raabe, E. H., Klein, A. M., Laetsch, T. W., McClellan, K., Rinkel, R. N. P. M., Saba, N. F., Sidell, D. R., Tansey, J. B., Tunkel, D. E., Young, G. D., & Zur, K. B. (2024). A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope, 134(12), 5041–5046. https://doi.org/10.1002/lary.31670